Bader-Meunier, B <br/><br/>
[Tolerance of biological agents in children].  [electronic resource] 

 -  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie  Jun 2010 
 - 962-3 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1769-664X 
<br/><br/><label>Standard No.: </label>10.1016/S0929-693X(10)70199-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abnormalities, Drug-Induced--etiology<br/>Adalimumab<br/>Adolescent<br/>Adverse Drug Reaction Reporting Systems<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Monoclonal, Murine-Derived--adverse effects<br/>Arthritis, Juvenile--drug therapy<br/>Biological Products--adverse effects<br/>Child<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Infant, Newborn<br/>Inflammatory Bowel Diseases--drug therapy<br/>Infliximab<br/>Pregnancy<br/>Psoriasis--drug therapy<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Risk<br/>Rituximab<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors